| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/27/2007 | US7183101 NCC2705—the genome of a bifidobacterium |
| 02/27/2007 | US7183099 Autoinducer is not an acyl-homoserine lactone and can interact with the Vibrio harveyi LuxQ protein, increasing expression of the operon; drug screening |
| 02/27/2007 | US7183095 Cell culture system for synthesis of infectious hepatitis C virus |
| 02/27/2007 | US7183090 Laccase enzyme and the gene encoding the enzyme |
| 02/27/2007 | US7183083 Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics |
| 02/27/2007 | US7183082 in vitro and in vivo; involves incorporating an unnatural amino acid into a protein and attaching one or more saccharide moieties to the unnatural amino acid; mimetics |
| 02/27/2007 | US7183081 Nucleotide sequences coding cytokine polypeptide for use in identifying modulator for treatment or arthritis, allergies, infections, inflammation, skin and cell proliferative disorders; wound healing agents |
| 02/27/2007 | US7183080 Cannie IL-5 nucleic acid molecules |
| 02/27/2007 | US7183079 Expression vector comprising synthetic promoter and nucleotide sequences coding cecropin proteins for use as tools to enhance disease resistance in catfish; bactericides; parasiticides |
| 02/27/2007 | US7183078 Nucleotide sequences coding mammalian histamine H4 receptor protein for use in diagnosis, prevention and treatment of asthma, allergy, inflammation, thrombotic, cardiovascular and autoimmune disorders |
| 02/27/2007 | US7183077 Promoters and gene expression method by using the promoters |
| 02/27/2007 | US7183075 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| 02/27/2007 | US7183070 Using reduction in beta site amyloid precursor protein cleaving enzyme activity, manifested as decreased beta amyloid peptides production, as diagnostic indicator of enzyme inhibition; for use in treatment of amyloid deposition disorders |
| 02/27/2007 | US7183066 Comprises substrate composition for detecting presence of tetanus and botulinum toxoids in neuronal tissues; food poisoning |
| 02/27/2007 | US7183065 Diagnosing ulcerative colitis in humans; obtain sample tissue, incubate with histone antigen, detect presence of complex formation, presence of complex indicates ulcerative colitis |
| 02/27/2007 | US7183063 Can be used in screening for agents which act as antagonists to MCP-1, MIP-1 alpha and/or RANTES |
| 02/27/2007 | US7183062 Prostaglandin receptor protein and methods of use thereof |
| 02/27/2007 | US7183061 Comprises nucleotide sequences coding heliothis ecdysone receptor for controlling gene transcrption in transgenic animal models |
| 02/27/2007 | US7183053 Diagnosing cancer in animal and humans via screens which detect extracellular viral nucleotide sequences associated with cell proliferative disease |
| 02/27/2007 | US7183047 Expression vector for use in the detection of viral proteins |
| 02/27/2007 | US7183046 Human polypeptide for use as an antitumor agent |
| 02/27/2007 | US7182947 Papillomavirus truncated L1 protein and fusion protein constructs |
| 02/27/2007 | US7182945 End group acylation; genetic engineering; rheumatic diseases, respiratory system disorders |
| 02/27/2007 | US7181884 Using pesticide to disrupt organic solute transporter/ligand-gated ion channel protein (CAATCH); biological pest control; amino acid-based targeted pesticides |
| 02/27/2007 | CA2286335C Methods of obtaining antigens specific for fungi, antibodies for such antigens, and diagnosis of disease using such antigens and/or antibodies |
| 02/27/2007 | CA2098253C Method for producing ectoprotein of hepatitis c virus |
| 02/22/2007 | WO2007022512A2 Glycopegylated factor vii and factor viia |
| 02/22/2007 | WO2007022425A2 Influenza recombinant subunit vaccine |
| 02/22/2007 | WO2007022287A2 Modified vegf and pdgf with improved angiogenic properties |
| 02/22/2007 | WO2007022273A2 Vegf-activated fas ligands |
| 02/22/2007 | WO2007022123A2 Hybrid polypeptides with selectable properties |
| 02/22/2007 | WO2007022012A2 Differentially protected orthogonal lanthionine technology |
| 02/22/2007 | WO2007021841A2 Identification and engineering of antibodies with variant fc regions and methods of using same |
| 02/22/2007 | WO2007021807A1 Mcp1 fusions |
| 02/22/2007 | WO2007021733A2 Methods and compositions for enhancing protein folding |
| 02/22/2007 | WO2007021498A1 Selective vpac2 receptor peptide agonists |
| 02/22/2007 | WO2007021494A2 Albumin fusion proteins |
| 02/22/2007 | WO2007021253A1 Compounds and methods for inhibiting hepatitis c virus replication |
| 02/22/2007 | WO2007021016A1 Photoregulated peptide, and method for regulation of peptide-protein complex formation using the photoregulated peptide |
| 02/22/2007 | WO2007020992A1 Dihydroxy-acid dehydratase gene and use thereof |
| 02/22/2007 | WO2007020989A1 Sulfate adenyltransferase gene and use thereof |
| 02/22/2007 | WO2007020898A1 Gene involved in silicon uptake and use thereof |
| 02/22/2007 | WO2007020889A1 Novel mucin glycoprotein and use thereof |
| 02/22/2007 | WO2007020880A1 Method of producing lymphocytes |
| 02/22/2007 | WO2007020853A1 Method for identifying target protein of agent and method for screening therapeutic agent for diabetes using target protein |
| 02/22/2007 | WO2007020645A1 Gene silencing of protease activated receptor 1 (par1) |
| 02/22/2007 | WO2007020617A2 Sequences of megaplasmid pmp118, chromosomal sequences and individual sequences thereof of lactobacillus salivarius strain ucc118 |
| 02/22/2007 | WO2007020402A1 Insulin-like growth factor ii (igf-ii) binding factors |
| 02/22/2007 | WO2007020291A1 Improving transglutaminase substrate specificity |
| 02/22/2007 | WO2007020290A1 Transglutaminase variants with improved specificity |
| 02/22/2007 | WO2007020256A1 Method for making mature insulin polypeptides |
| 02/22/2007 | WO2007020243A2 Vaccine based on virus-neutralizing antibodies |
| 02/22/2007 | WO2007020198A2 Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress |
| 02/22/2007 | WO2007020026A1 Isolation of the t-complex distorters and applications thereof |
| 02/22/2007 | WO2007020017A1 Composition for bird immunization administered by aerosol |
| 02/22/2007 | WO2007019949A1 Fusion proteins between plant cell-wall degrading enzymes, and their uses |
| 02/22/2007 | WO2006134280A3 Mutated nucleotide sequences of the hepatitis c virus |
| 02/22/2007 | WO2006134190A3 Agents and methods based on the use of the eda domain of fibronectin |
| 02/22/2007 | WO2006133316A3 Tumor suppressor gene caliban |
| 02/22/2007 | WO2006128668A3 Coagulation factor x polypeptides with modified activation properties |
| 02/22/2007 | WO2006125632A3 Agonistic antibodies that bind to the tweak receptor fn14 and thereby modulate adiposity-associated phenotypes as well as their use in therapy |
| 02/22/2007 | WO2006120579A3 Methods for detecting virulent plasmodium, for evaluating plasmodium virulence, and for screening new drugs employing the 3'utr of plasmodium sub2 and the plasmodium sub2 serine protease |
| 02/22/2007 | WO2006119510A3 Isoforms of receptor for advanced glycation end products (rage) and methods of identifying and using same |
| 02/22/2007 | WO2006103472A3 Soluble vox2 protein as immunoregulatory factor |
| 02/22/2007 | WO2006098998A9 Methods and compositions for modulating vascular integrity |
| 02/22/2007 | WO2006097694A3 Peptide synthesis supported by a soluble polymer |
| 02/22/2007 | WO2006092338A3 Tnf-alpha binding polypeptide , uses thereof and methods employing it |
| 02/22/2007 | WO2006091899A3 Epidermal growth factor receptor mutations |
| 02/22/2007 | WO2006084007A3 Novel gene underlying atherosclerosis locus i |
| 02/22/2007 | WO2006081272A3 Compositions and methods for the diagnosis and treatment of tumor |
| 02/22/2007 | WO2006076189A3 Maize cyclo1 gene and promoter |
| 02/22/2007 | WO2006063028A3 Immunostimulatory compositions and uses thereof |
| 02/22/2007 | WO2006058243A3 Leishmania antigens and related compositions and uses |
| 02/22/2007 | WO2005111060A3 Molecules involved in protein folding and methods op identifying them |
| 02/22/2007 | WO2005072367A3 High protein soybean meal |
| 02/22/2007 | WO2005062957A3 Compositions and methods for combined therapy of disease |
| 02/22/2007 | WO2005042725A3 Liver cancer biomarkers |
| 02/22/2007 | WO2005037994A3 Transgenic rodents selectively expressing human b1 bradykinin receptor protein |
| 02/22/2007 | WO2004108748A3 Growth arrest specific gene 6 peptides, antibodies, compositions, methods and uses |
| 02/22/2007 | WO2004094467A3 H. pylori antigens |
| 02/22/2007 | WO2004090103A8 Identification of novel nogo-receptors and methods related thereto |
| 02/22/2007 | WO2004085616A3 Regulation of self-renewal in stem cells |
| 02/22/2007 | WO2004074436A3 Methods of use of a gpcr in the diagnosis and treatment of colon and lung cancer |
| 02/22/2007 | WO2004058800A3 Mammalian cell culture processes for protein production |
| 02/22/2007 | US20070044181 Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
| 02/22/2007 | US20070044178 AXMI-028 and AXMI-029, a family of novel delta-endotoxin genes and methods for their use |
| 02/22/2007 | US20070044176 Nitrate transport components |
| 02/22/2007 | US20070044175 Genes conferring herbicide resistance |
| 02/22/2007 | US20070044172 use of nucleotide sequences in the genetic-engineering of plants to display enhanced nitrogen assimilatory and utilization capacities, grow larger, more efficiently or rapidly, and/or have enriched nitrogen contents in vegetative and/or reproductive plant parts and/or increased biomass |
| 02/22/2007 | US20070044171 Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
| 02/22/2007 | US20070044166 P2Y4 Receptor transgenic and knockout non-human mammals |
| 02/22/2007 | US20070044163 Interferon gamma-like protein |
| 02/22/2007 | US20070044162 Transgenic rat as animal model for human huntingdon's disease |
| 02/22/2007 | US20070043212 Crown ether derivatives |
| 02/22/2007 | US20070043211 Mammalian transforming growth factor beta-9 |
| 02/22/2007 | US20070043210 Produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins; has anti-hepatitis activity; culturing |
| 02/22/2007 | US20070043209 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides |
| 02/22/2007 | US20070043208 Crystal structure of erythrocyte binding domain of EBA-175 |
| 02/22/2007 | US20070042981 Use of eukaryotic genes affecting chromatin separation for diagnosis and treatment of proliferative diseases |
| 02/22/2007 | US20070042978 Nf-hev compositions and methods of use |